Single Arm Clinical Trial (Gut Microbiota and HCC)

Summary

To evaluate the efficacy and safety of oral enterobacterial capsules in patients with intermediate and advanced HCC who have progressed after treating with immune checkpoint inhibitors in combination with anti-angiogenesis targeted agents.

Timeline

Start

2024-08-24

Primary completion

2026-05-20

Completion

2026-11-20

Drugs

Indications